Foresite Capital Management V, LLC Diversified Active

Name: Foresite Capital Management V, LLC Q4 2021 13F Filing | 13F Explorer
Creator: Foresite Capital Management V, LLC
Published: 2022-02-11

Location: West Hollywood, CA

CIK: 0001792206 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 11, 2022

Total Value: $407M (100.0% shares, 0.0% debt)

Holdings (16)

— Pardes Biosciences Inc 37.8%

Value $154M Shares 9,400,515 Est. Cost $16.37 Unrealized —

— Somalogic, Inc. 15.2%

Value $62M Shares 5,326,472 Est. Cost $12.39 Unrealized —

— TheseusPharmaceuticals, Inc. 10.0%

Value $40.74M Shares 3,212,732 Est. Cost $12.68 Unrealized —

QSI Quantum-Si Incorporated 4.5%

Value $18.43M Shares 2,342,061 Est. Cost $10.48 Unrealized -28.1%

ACRS Aclaris Therapeutics, Inc. 4.5%

Value $18.3M Shares 1,258,243 Est. Cost $19.56 Unrealized -22.5%

CGEM Cullinan Oncology, Inc. 4.3%

Value $17.64M Shares 1,143,006 Est. Cost $40.60 Unrealized -50.9%

HLTHQ Cue Health Inc. 3.8%

Value $15.66M Shares 1,167,782 Est. Cost $11.81 Unrealized —

— Kinnate Biopharma Inc. 3.8%

Value $15.51M Shares 875,001 Est. Cost $39.78 Unrealized —

CMPX Compass Therapeutics, Inc. 3.4%

Value $13.95M Shares 4,400,000 Est. Cost $3.29 Unrealized 0.0%

IVVD Adagio Therapeutics, Inc. 3.1%

Value $12.67M Shares 1,745,060 Est. Cost $34.15 Unrealized -23.9%

— Adicet Bio, Inc. 2.9%

Value $11.89M Shares 680,000 Est. Cost $17.49 Unrealized —

HIMS Hims & Hers Health, Inc. 2.7%

Value $11.18M Shares 1,706,922 Est. Cost $13.13 Unrealized -44.9%

— Gemini Therapeutics, Inc. 1.7%

Value $7.086M Shares 2,435,125 Est. Cost $13.55 Unrealized —

— Research Alliance Corp. II 1.2%

Value $4.885M Shares 500,000 Est. Cost $10.25 Unrealized —

— 23andMe Holding Co. 0.7%

Value $2.71M Shares 406,913 Est. Cost $11.69 Unrealized —

PHVS Pharvaris N.V. 0.1%

Value $491K Shares 34,142 Est. Cost $31.46 Unrealized -50.3%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Pardes Biosciences Inc	9,400,515	$154M	37.8%	$16.37	—	COM	69945Q105
—	Somalogic, Inc.	5,326,472	$62M	15.2%	$12.39	—	COM CL A	83444K105
—	TheseusPharmaceuticals, Inc.	3,212,732	$40.74M	10.0%	$12.68	—	COM	88369M101
QSI	Quantum-Si Incorporated	2,342,061	$18.43M	4.5%	$10.48	-28.1%	COM CL A	74765K105
ACRS	Aclaris Therapeutics, Inc.	1,258,243	$18.3M	4.5%	$19.56	-22.5%	COM	00461U105
CGEM	Cullinan Oncology, Inc.	1,143,006	$17.64M	4.3%	$40.60	-50.9%	COM	230031106
HLTHQ	Cue Health Inc.	1,167,782	$15.66M	3.8%	$11.81	—	COM	229790100
—	Kinnate Biopharma Inc.	875,001	$15.51M	3.8%	$39.78	—	COM	49705R105
CMPX	Compass Therapeutics, Inc.	4,400,000	$13.95M	3.4%	$3.29	0.0%	COM	20454B104
IVVD	Adagio Therapeutics, Inc.	1,745,060	$12.67M	3.1%	$34.15	-23.9%	COM	00534A102
—	Adicet Bio, Inc.	680,000	$11.89M	2.9%	$17.49	—	COM	007002108
HIMS	Hims & Hers Health, Inc.	1,706,922	$11.18M	2.7%	$13.13	-44.9%	COM CL A	433000106
—	Gemini Therapeutics, Inc.	2,435,125	$7.086M	1.7%	$13.55	—	COM	36870G105
—	Research Alliance Corp. II	500,000	$4.885M	1.2%	$10.25	—	COM CL A	760873109
—	23andMe Holding Co.	406,913	$2.71M	0.7%	$11.69	—	COM CL A	90138Q108
PHVS	Pharvaris N.V.	34,142	$491K	0.1%	$31.46	-50.3%	COM	N69605108